查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390743

2023-2028 年智慧药丸市场报告（按目标领域、疾病适应症、应用、最终用户和地区）

Smart Pills Market Report by Target Area, Disease Indication, Application, End User, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 138 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球智慧药丸市场规模达到43亿美元。展望未来， IMARC Group预计到2028年市场规模将达到67亿美元，2022-2028年复合年增长率（CAGR）为7.67%。老年族群对慢性病管理的需求增加、技术的快速进步、微创手术（MIS）的新兴趋势、製药业对个人化医疗和药物输送的日益关注是推动市场的一些主要因素。

智慧药丸，也称为数位药丸或可摄入感测器，是一种创新药物，配备微型电子元件，可实现远端监控和资料收集。这些药丸通常包含感测器、微晶片和发射器，供患者服用。一旦进入体内，它们就会与体液相互作用，将有关患者健康指标、药物依从性和生理反应的即时资料发送到外部设备。医疗保健提供者和研究人员利用这些资料来加强患者护理、优化治疗计划并改善药物开发。智慧药丸透过增强监测和资料收集能力，为个人化医疗、慢性病管理和临床试验提供潜在好处。

在全球人口老化的推动下，全球智慧药丸市场正在经历大幅成长，导致慢性病盛行率增加，需要对患者的健康状况进行持续监测和管理。智慧药丸提供了一种非侵入性且有效的方式来收集即时健康资料，使其成为远端患者监测和疾病管理的宝贵工具。此外，微型电子和无线通讯技术的进步使得开发和生产智慧药丸更具成本效益，增加了医疗保健提供者和患者的可及性，这为市场扩张创造了积极的前景。除此之外，对个人化医疗的需求不断增长以及对精确药物输送系统的需求促使製药公司和研究人员投资智慧药丸技术，也促进了市场的成长。此外，COVID-19 大流行推动了远距医疗和远端监控解决方案的采用，进一步推动了智慧药丸市场的发展。

智慧药丸市场趋势/驱动因素：

人口老化与慢性病管理

一个重要的驱动因素是全球老年人口的增加。随着人口平均年龄的增加，糖尿病、高血压、心血管疾病等慢性疾病的盛行率也增加。管理这些病症通常需要持续监测和坚持用药。智慧药丸透过提供有关患者健康指标的非侵入性即时资料收集来提供创新的解决方案。这种远端监测功能对于难以采用传统监测方法的老年患者尤其有价值。医疗保健提供者可以利用智慧药丸的资料及时进行干预，调整治疗计划，并确保更好的疾病管理，从而提高老龄化人口的护理品质。

持续的技术进步

微型电子、感测器和无线通讯技术的进步极大地促进了智慧药丸市场的成长。这些技术进步促进了更小、更容易服用的智慧药丸的开发，提高了患者的舒适度和依从性，同时减少了服用过程中出现不适或阻力的可能性。此外，组件的小型化不仅降低了製造成本，还提高了智慧药丸的整体效率和寿命。因此，医疗保健提供者和患者受益于更容易获得和更具成本效益的解决方案，而智慧药丸收集的资料的准确性和可靠性得到了提高，在医学界得到了越来越多的认可，有助于市场扩张。

对个人化医疗和新型药物输送的需求不断增长

製药业对个人化医疗和精确药物输送系统日益增长的兴趣是另一个驱动因素。智慧药丸提供了一种将药物直接给药到体内目标部位的独特方法。这种标靶药物传递可以增强治疗效果，同时最大限度地减少副作用。製药公司越来越多地投资智慧药丸技术，作为改善药物开发的手段，确保药物适合个别患者的需求。除此之外，智慧药丸还可用于临床试验，收集药物效果的即时资料，简化研究过程，并有可能加快新疗法推向市场的速度。

智慧药丸产业细分：

IMARC Group提供了每个细分市场的主要趋势的分析，以及 2023 年至 2028 年全球、区域和国家层面的预测。我们的报告根据目标区域、疾病适应症、应用和最终用户对市场进行了分类。

按目标区域划分：

食道

小肠

大肠

胃

小肠占据市场主导地位

该报告根据目标区域提供了详细的市场区隔和分析。这包括食道、小肠、大肠和胃。根据报告，小肠是最大的部分。

针对小肠的智慧药丸的需求源自于其独特的进入和监测消化道特定区域的能力。小肠在营养吸收中起着至关重要的作用，使其成为各种胃肠道疾病和药物传输挑战的焦点。设计用于该区域的智慧药丸可以精确了解营养吸收效率，从而可以针对吸收不良综合征等病症提供量身定制的饮食建议和治疗方法。此外，它们的应用也扩展到药物传输优化，确保药物到达预期的作用部位，这对于需要在小肠吸收的治疗尤其相关。因此，由于其满足特定医疗保健需求和增强治疗效果的潜力，对小肠量身定制的智慧药丸的需求持续上升。

按疾病指示细分：

食道疾病

小肠疾病

结肠疾病

其他的

报告还根据疾病迹象提供了详细的市场细分和分析。这包括食道疾病、小肠疾病、结肠疾病等。

由于智慧药丸能够在胃肠道的这些特定区域提供精确、即时的资料，因此对治疗食道、小肠和结肠疾病的智慧药丸的需求激增，这正在加强市场的成长。此外，胃食道逆流症 (GERD) 等食道疾病的盛行率不断上升，其中智慧药丸有助于监测 pH 值并追踪胃酸逆流模式，从而有助于诊断和管理这些疾病。除此之外，在克罗恩病或乳糜泻等小肠疾病中，这些药丸可以帮助追踪通过和运输时间，使临床医生能够评估肠道蠕动和炎症，而在结肠疾病，特别是结直肠癌筛查中，配备成像功能的智慧药丸可以捕捉详细的影像，增强早期检测并减少侵入性手术的需要。这种有针对性的监测和诊断潜力正在推动食道、小肠和结肠疾病领域对智慧药丸的需求，从而改善患者护理和治疗结果。

按应用划分：

胶囊内视镜

药物输送

病人监护

胶囊内视镜主导市场

该报告根据应用程式提供了详细的市场细分和分析。这包括胶囊内视镜检查、药物传输和患者监测。根据该报告，胶囊内视镜占最大部分。

与传统内视镜检查不同，配备成像技术的智慧药丸为胃肠道可视化提供了一种无痛且患者友好的替代方案。这导致了接受度和患者依从性的提高，特别是在传统内视镜检查可能不舒服或具有挑战性的情况下。此外，使用智慧药丸进行胶囊内视镜检查对于诊断和监测不明原因胃肠道出血、克隆氏症和小肠肿瘤等疾病特别有价值。这些智慧药丸捕获的高品质影像和即时资料可以实现早期检测和精确定位异常，从而促进及时干预并改善患者治疗结果。因此，胶囊内视镜对智慧药丸的需求持续增长，从而提高了医疗保健专业人员的诊断能力和患者体验。

按最终用户划分：

医院

诊断中心

研究机构

诊断中心占市场最大份额

报告还提供了基于最终用户的详细市场细分和分析。这包括医院、诊断中心和研究机构。报告称，诊断中心占据最大的市场份额。

诊断中心对智慧药丸的需求不断增长，透过提供一种对患者友好、非侵入性的方法来增强诊断程序，从而促进了市场的扩张。这些设备提供即时胃肠道资料，有助于精确诊断，特别是对于胃肠道出血、蠕动障碍和小肠疾病等疾病。智慧药丸的成像功能、pH 评估和传输监测为临床医生提供了胃肠道健康的全面视图，减少了对不舒服的侵入性手术的需求。这提高了患者的舒适度、依从性和诊断准确性，使患者和医疗保健提供者受益，并有助于诊断中心越来越多地采用智慧药丸。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的智慧药丸市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

北美强大的医疗基础设施，包括先进的诊断中心和研究机构，正在促进智慧药丸用于创新诊断和研究目的的采用。同时，发炎性肠道疾病和大肠直肠癌等胃肠道疾病的盛行率不断上升，对智慧药丸等非侵入性诊断工具产生了很高的需求，这些工具可以提高患者的舒适度和依从性。此外，该地区的人口老化以及对慢性病管理的需求不断增长，将智慧药丸视为远端患者监测的宝贵解决方案。除此之外，北美有利的报销政策和监管框架正在鼓励医疗保健提供者和製药公司投资智慧药丸技术。除此之外，该地区的技术创新和领先公司的早期市场进入为北美智慧药丸市场的成长奠定了坚实的基础。

竞争格局：

全球智慧药丸市场呈现出一个竞争格局，既有老牌企业，也有新兴企业，他们都在努力利用对远距病患监测和创新医疗解决方案不断增长的需求。领先企业凭藉较早的市场进入、强大的研发能力和广泛的分销网络占据了巨大的市场份额。他们提供各种智慧药丸产品，融合了先进的感测器技术和资料分析平台。此外，与医疗保健提供者和製药公司的伙伴关係和合作进一步巩固了他们的市场地位。同时，许多新创公司和小型公司正在透过颠覆性技术和智慧药丸的新颖应用积极为市场成长做出贡献，加剧竞争并推动产业创新。

市场研究报告对竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

凯普索视觉公司

检查帽有限公司

通用电气公司

英卓医疗股份有限公司

金山科技（集团）有限公司

皇家飞利浦公司

美敦力公司

奥林巴斯公司

宾得医疗（豪雅公司）。

（请注意，这只是关键参与者的部分列表，报告中提供了完整列表。）

最近的发展：

2020 年，CapsoVision Inc.（美国）的总部和 CapsoCloud 软体都获得了 ISO 27001 安全认证，并重申了对保护客户资料的坚定不移的承诺。

本报告回答的关键问题：

  • 迄今为止，全球智慧药丸市场表现如何，未来几年将如何表现？
  • 全球智慧药丸市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球智慧药丸市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的智慧药丸市场？
  • 基于目标区域的市场区隔是什么？
  • 智慧药丸市场最有吸引力的目标领域是哪个？
  • 根据疾病迹象，市场的细分是什么？
  • 智慧药丸市场上最具吸引力的疾病适应症是什么？
  • 基于应用程式的市场区隔是什么？
  • 智慧药丸市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 智慧药丸市场中哪一个对最终用户最具吸引力？
  • 全球智慧药丸市场竞争格局如何？
  • 谁是全球智慧药丸市场的主要参与者/公司？

本报告回答的关键问题：

  • 迄今为止，全球智慧药丸市场表现如何，未来几年将如何表现？
  • 全球智慧药丸市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球智慧药丸市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的智慧药丸市场？
  • 基于目标区域的市场区隔是什么？
  • 智慧药丸市场最有吸引力的目标领域是哪个？
  • 根据疾病迹象，市场的细分是什么？
  • 智慧药丸市场上最具吸引力的疾病适应症是什么？
  • 基于应用程式的市场区隔是什么？
  • 智慧药丸市场中最具吸引力的应用是什么？
  • 基于最终用户的市场区隔是什么？
  • 智慧药丸市场中哪一个对最终用户最具吸引力？
  • 全球智慧药丸市场竞争格局如何？
  • 谁是全球智慧药丸市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球智慧药丸市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按目标区域分類的市场区隔

  • 食道
    • 市场走向
    • 市场预测
  • 小肠
    • 市场走向
    • 市场预测
  • 大肠
    • 市场走向
    • 市场预测
  • 胃
    • 市场走向
    • 市场预测

第 7 章：依疾病适应症分類的市场

  • 食道疾病
    • 市场走向
    • 市场预测
  • 小肠疾病
    • 市场走向
    • 市场预测
  • 结肠疾病
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按应用分類的市场区隔

  • 胶囊内视镜
    • 市场走向
    • 市场预测
  • 药物输送
    • 市场走向
    • 市场预测
  • 病人监护
    • 市场走向
    • 市场预测

第 9 章：最终用户的市场区隔

  • 医院
    • 市场走向
    • 市场预测
  • 诊断中心
    • 市场走向
    • 市场预测
  • 研究机构
    • 市场走向
    • 市场预测

第 10 章：按地区分類的市场细分

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • CapsoVision Inc.
    • Check-Cap Ltd.
    • General Electric Company
    • IntroMedic Co. Ltd.
    • Jinshan Science & Technology (Group) Co. Ltd.
    • Koninklijke Philips NV
    • Medtronic plc
    • Olympus Corporation
    • PENTAX Medical (Hoya Corporation)
Product Code: SR112023A4568

Abstract

The global smart pills market size reached US$ 4.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.67% during 2022-2028. The increased demand for chronic disease management among the geriatric population, rapid technological advancements, emerging trend of minimally invasive surgeries (MIS), the increasing focus of pharmaceutical industry on personalized medicine and drug delivery are some of the major factors propelling the market.

Smart pills, also known as digital pills or ingestible sensors, are innovative pharmaceuticals equipped with tiny electronic components that enable remote monitoring and data collection. These pills typically contain sensors, microchips, and transmitters, which are ingested by patients. Once inside the body, they interact with bodily fluids, sending real-time data about a patient's health metrics, medication adherence, and physiological responses to external devices. Healthcare providers and researchers use this data to enhance patient care, optimize treatment plans, and improve drug development. Smart pills offer potential benefits in personalized medicine, chronic disease management, and clinical trials by enhancing monitoring and data acquisition capabilities.

The global smart pills market is experiencing substantial growth driven by the aging population across the globe has resulted in an increased prevalence of chronic diseases, requiring continuous monitoring and management of patient's health. Smart pills offer a non-invasive and efficient way to collect real-time health data, making them a valuable tool for remote patient monitoring and disease management. Moreover, advancements in miniaturized electronics and wireless communication technologies have made it more cost-effective to develop and produce smart pills, increasing their accessibility to healthcare providers and patients, which is creating a positive outlook for market expansion. In addition to this, the rising demand for personalized medicine and the need for precise drug delivery systems prompting pharmaceutical companies and researchers to invest in smart pill technology, are contributing to the market growth. Furthermore, the COVID-19 pandemic has fueled the adoption of telehealth and remote monitoring solutions, further boosting the market for smart pills.

Smart Pills Market Trends/Drivers:

Aging population and chronic disease management

One significant driver is the increasing geriatric population across the globe. As the average age of the population rises, so does the prevalence of chronic diseases such as diabetes, hypertension, and cardiovascular diseases. Managing these conditions often requires continuous monitoring and medication adherence. Smart pills provide an innovative solution by offering non-invasive, real-time data collection on a patient's health metrics. This remote monitoring capability is particularly valuable for elderly patients who may have difficulty with conventional monitoring methods. Healthcare providers can use the data from smart pills to make timely interventions, adjust treatment plans, and ensure better disease management, improving the quality of care for aging populations.

Ongoing technological advancements

Advancements in miniaturized electronics, sensors, and wireless communication technologies have significantly contributed to the growth of the smart pills market. These technological strides have led to the development of smaller, more easily ingestible smart pills, enhancing patient comfort and compliance while reducing the potential for discomfort or resistance during ingestion. Moreover, the miniaturization of components has not only reduced manufacturing costs but also improved the overall efficiency and longevity of smart pills. As a result, healthcare providers and patients benefit from more accessible and cost-effective solutions, while the enhanced accuracy and reliability of the data collected by smart pills have garnered increased acceptance within the medical community, aiding in market expansion.

Growing demand for personalized medicine and novel drug delivery

The pharmaceutical industry's growing interest in personalized medicine and precise drug delivery systems is another driving factor. Smart pills offer a unique way to administer medications directly to the target site in the body. This targeted drug delivery can enhance the efficacy of treatments while minimizing side effects. Pharmaceutical companies are increasingly investing in smart pill technology as a means to improve drug development, ensuring that medications are tailored to individual patient needs. Apart from this, smart pills can be used in clinical trials to gather real-time data on the drug's effects, streamlining the research process and potentially speeding up the introduction of new therapies to the market.

Smart Pills Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on target area, disease indication, application and end user.

Breakup by Target Area:

Esophagus

Small Intestine

Large Intestine

Stomach

Small intestine dominate the market

The report has provided a detailed breakup and analysis of the market based on the target area. This includes esophagus, small intestine, large intestine, and stomach. According to the report, small intestine represented the largest segment.

The demand for smart pills targeting the small intestine is propelled by their unique ability to access and monitor this specific area of the digestive tract. The small intestine plays a crucial role in nutrient absorption, making it a focal point for various gastrointestinal disorders and drug delivery challenges. Smart pills designed to operate in this region offer precise insights into nutrient absorption efficiency, allowing for tailored dietary recommendations and treatments for conditions, such as malabsorption syndromes. Furthermore, their application extends to drug delivery optimization, ensuring medications reach the intended site of action, which is especially relevant for treatments that require absorption in the small intestine. As a result, the demand for smart pills tailored to the small intestine continues to rise, driven by their potential to address specific healthcare needs and enhance therapeutic outcomes.

Breakup by Disease Indication:

Esophageal Diseases

Small Bowel Diseases

Colon Diseases

Others

A detailed breakup and analysis of the market based on the disease indication have also been provided in the report. This includes esophageal diseases, small bowel diseases, colon diseases, and others.

The surging demand for smart pills in addressing esophageal, small bowel, and colon diseases owing to their capacity to provide precise, real-time data in these specific areas of the gastrointestinal tract is strengthening the market growth. Moreover, the growing prevalence of esophageal diseases such as gastroesophageal reflux disease (GERD), wherein smart pills help monitor pH levels and track acid reflux patterns, aiding in the diagnosis and management of these conditions. Apart from this, in small bowel diseases like Crohn's disease or celiac disease, these pills can help track the passage and transit time, enabling clinicians to assess motility and inflammation, while in colon diseases, particularly colorectal cancer screening, smart pills equipped with imaging capabilities can capture detailed images, enhancing early detection and reducing the need for invasive procedures. This targeted monitoring and diagnostic potential are propelling the demand for smart pills in the context of esophageal, small bowel, and colon diseases, improving patient care and outcomes.

Breakup by Application:

Capsule Endoscopy

Drug Delivery

Patient Monitoring

Capsule endoscopy dominate the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes capsule endoscopy, drug delivery, and patient monitoring. According to the report, capsule endoscopy represented the largest segment.

Unlike traditional endoscopy, smart pills equipped with imaging technology provide a painless and patient-friendly alternative for visualizing the gastrointestinal tract. This has led to increased acceptance and patient compliance, especially in cases where traditional endoscopy may be uncomfortable or challenging. Additionally, capsule endoscopy using smart pills is particularly valuable for diagnosing and monitoring conditions such as obscure gastrointestinal bleeding, Crohn's disease, and small bowel tumors. The high-quality images and real-time data captured by these smart pills allow for early detection and precise localization of abnormalities, thereby facilitating timely interventions and improving patient outcomes. Consequently, the demand for smart pills in capsule endoscopy continues to grow, enhancing the diagnostic capabilities of healthcare professionals and patient experiences.

Breakup by End User:

Hospitals

Diagnostic Centers

Research Institutes

Diagnostic centers hold the largest share in the market

A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, diagnostic centers, and research institutes. According to the report, diagnostic centers accounted for the largest market share.

The rising demand for smart pills in diagnostic centers is bolstering market expansion by offering a patient-friendly, non-invasive approach to enhance diagnostic procedures. These devices provide real-time gastrointestinal data, aiding precise diagnoses, especially for conditions like gastrointestinal bleeding, motility disorders, and small bowel diseases. Smart pills' imaging capabilities, pH assessment, and transit monitoring provide clinicians with a comprehensive view of GI health, reducing the need for uncomfortable invasive procedures. This improves patient comfort, compliance, and diagnostic accuracy, benefiting both patients and healthcare providers, and contributing to the growing adoption of smart pills in diagnostic centers.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest smart pills market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America's robust healthcare infrastructure, including advanced diagnostic centers and research institutions, is facilitating the adoption of smart pills for innovative diagnostic and research purposes. Concurrently, the increasing prevalence of gastrointestinal disorders, such as inflammatory bowel disease and colorectal cancer, has created a high demand for non-invasive diagnostic tools like smart pills, which offer improved patient comfort and compliance. Moreover, the region's aging population, with a growing need for chronic disease management, sees smart pills as an invaluable solution for remote patient monitoring. Besides this, favorable reimbursement policies and regulatory frameworks in North America are encouraging healthcare providers and pharmaceutical companies to invest in smart pill technology. Apart from this, the region's technological innovation and early market entry by leading companies have established a strong foundation for the growth of the North America smart pills market.

Competitive Landscape:

The global smart pills market presents a competitive landscape characterized by a mix of established players and emerging entrants striving to capitalize on the growing demand for remote patient monitoring and innovative healthcare solutions. Leading companies hold substantial market shares, primarily due to their early market entry, robust R&D capabilities, and extensive distribution networks. They offer a diverse range of smart pill products, incorporating advanced sensor technologies and data analytics platforms. Moreover, partnerships and collaborations with healthcare providers and pharmaceutical companies have further solidified their market position. At the same time, numerous startups and smaller companies, are actively contributing to market growth with disruptive technologies and novel applications of smart pills, intensifying competition and driving innovation in the industry.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

CapsoVision Inc

Check-Cap Ltd.

General Electric Company

IntroMedic Co. Ltd.

Jinshan Science & Technology (Group) Co. Ltd.

Koninklijke Philips N.V.

Medtronic plc

Olympus Corporation

PENTAX Medical (Hoya Corporation).

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Recent Developments:

In 2020, CapsoVision Inc. (US) attained ISO 27001 security certification for both its headquarters and CapsoCloud software, reaffirming its unwavering dedication to safeguarding customer data.

Key Questions Answered in This Report:

  • How has the global smart pills market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global smart pills market?
  • What is the impact of each driver, restraint, and opportunity on the global smart pills market?
  • What are the key regional markets?
  • Which countries represent the most attractive smart pills market?
  • What is the breakup of the market based on the target area?
  • Which is the most attractive target area in the smart pills market?
  • What is the breakup of the market based on the disease indication?
  • Which is the most attractive disease indication in the smart pills market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the smart pills market?
  • What is the breakup of the market based on the end user?
  • Which is the most attractive end user in the smart pills market?
  • What is the competitive structure of the global smart pills market?
  • Who are the key players/companies in the global smart pills market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Smart Pills Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Target Area

  • 6.1 Esophagus
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Small Intestine
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Large Intestine
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Stomach
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Disease Indication

  • 7.1 Esophageal Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Small Bowel Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Colon Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Capsule Endoscopy
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Drug Delivery
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Patient Monitoring
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Centers
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Institutes
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 CapsoVision Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Check-Cap Ltd.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 General Electric Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 IntroMedic Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Jinshan Science & Technology (Group) Co. Ltd.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Koninklijke Philips N.V.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Medtronic plc
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Olympus Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PENTAX Medical (Hoya Corporation)
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio

List of Figures

  • Figure 1: Global: Smart Pills Market: Major Drivers and Challenges
  • Figure 2: Global: Smart Pills Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Smart Pills Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Smart Pills Market: Breakup by Target Area (in %), 2022
  • Figure 5: Global: Smart Pills Market: Breakup by Disease Indication (in %), 2022
  • Figure 6: Global: Smart Pills Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Smart Pills Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Smart Pills Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Smart Pills (Esophagus) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Smart Pills (Esophagus) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Smart Pills (Small Intestine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Smart Pills (Small Intestine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Smart Pills (Large Intestine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Smart Pills (Large Intestine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Smart Pills (Stomach) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Smart Pills (Stomach) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Smart Pills (Esophageal Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Smart Pills (Esophageal Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Smart Pills (Small Bowel Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Smart Pills (Small Bowel Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Smart Pills (Colon Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Smart Pills (Colon Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Smart Pills (Other Disease Indications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Smart Pills (Other Disease Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Smart Pills (Capsule Endoscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Smart Pills (Capsule Endoscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Smart Pills (Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Smart Pills (Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Smart Pills (Patient Monitoring) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Smart Pills (Patient Monitoring) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: Global: Smart Pills (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: Global: Smart Pills (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: Global: Smart Pills (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: Global: Smart Pills (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Global: Smart Pills (Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Global: Smart Pills (Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: North America: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: North America: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: United States: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: United States: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Canada: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Canada: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: Asia-Pacific: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: Asia-Pacific: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: China: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: China: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Japan: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Japan: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: India: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: India: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: South Korea: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: South Korea: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Australia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Australia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Indonesia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Indonesia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: Europe: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: Europe: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Germany: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Germany: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: France: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: France: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: United Kingdom: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: United Kingdom: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Italy: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Italy: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Spain: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Spain: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Russia: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Russia: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Latin America: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Latin America: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Brazil: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Brazil: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 79: Mexico: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 80: Mexico: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 81: Others: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 82: Others: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Middle East and Africa: Smart Pills Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 84: Middle East and Africa: Smart Pills Market: Breakup by Country (in %), 2022
  • Figure 85: Middle East and Africa: Smart Pills Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Global: Smart Pills Industry: SWOT Analysis
  • Figure 87: Global: Smart Pills Industry: Value Chain Analysis
  • Figure 88: Global: Smart Pills Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Smart Pills Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Smart Pills Market Forecast: Breakup by Target Area (in Million US$), 2023-2028
  • Table 3: Global: Smart Pills Market Forecast: Breakup by Disease Indication (in Million US$), 2023-2028
  • Table 4: Global: Smart Pills Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Smart Pills Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Smart Pills Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Smart Pills Market: Competitive Structure
  • Table 8: Global: Smart Pills Market: Key Players